YCBD (STOCKS)
cbdMD, Inc. Common Stock
$0.723300
+0.043200 (+6.35%)
Prev close: $0.680100
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- T. Ronan Kennedy
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.75M
- Employees
- 42
- P/E (TTM)
- -0.31
- P/B (TTM)
- 0.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q1)
|
$-0.04 | $-0.06 | +0.0212 | +34.64% |
|
Sep 2025 (Q4)
|
$-0.17 | $-0.07 | -0.0986 | -138.10% |
|
Jun 2025 (Q3)
|
$-0.21 | $-0.02 | -0.1896 | -929.41% |
|
Mar 2025 (Q2)
|
$-1.90 | $-1.63 | -0.2680 | -16.42% |
Financial Statements
| Revenues | $19.09M |
| Benefits Costs and Expenses | $21.43M |
| Cost Of Revenue | $7.52M |
| Costs And Expenses | $21.43M |
| Gross Profit | $11.57M |
| Operating Expenses | $13.93M |
| Operating Income/Loss | -$2.36M |
| Income/Loss From Continuing Operations After Tax | -$2.34M |
| Income/Loss From Continuing Operations Before Tax | -$2.34M |
| Interest Income/Expense After Provision For Losses | $26.06K |
| Interest Income/Expense Operating, Net | $26.06K |
| Net Income/Loss | -$2.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.34M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $374.97K |
| Preferred Stock Dividends And Other Adjustments | $374.97K |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$1.68 |
| Basic Average Shares | 17,212,187 |
| Assets | $11.78M |
| Current Assets | $8.17M |
| Inventory | $3.14M |
| Other Current Assets | $5.02M |
| Noncurrent Assets | $3.62M |
| Fixed Assets | $388.02K |
| Intangible Assets | $1.93M |
| Other Non-current Assets | $1.30M |
| Liabilities | $2.77M |
| Current Liabilities | $2.77M |
| Accounts Payable | $880.98K |
| Other Current Liabilities | $1.89M |
| Noncurrent Liabilities | $0.00 |
| Equity | $9.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.01M |
| Liabilities And Equity | $11.78M |
| Net Cash Flow From Operating Activities | -$1.95M |
| Net Cash Flow From Operating Activities, Continuing | -$1.95M |
| Net Cash Flow From Investing Activities | -$184.59K |
| Net Cash Flow From Investing Activities, Continuing | -$184.59K |
| Net Cash Flow From Financing Activities | $3.07M |
| Net Cash Flow From Financing Activities, Continuing | $3.07M |
| Net Cash Flow | $935.38K |
| Net Cash Flow, Continuing | $935.38K |
| Comprehensive Income/Loss | -$2.67M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.67M |
| Other Comprehensive Income/Loss | -$1.23M |